Haemophilus Influenzae

• HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.ICD-10: R05.9

DIRECTIONS: One tablet three times daily or as directed by a health professional.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a health professional before use. Tamper seal: Sealed for your protection. Do not use if seal is broken or missing.

Recent PubMed references pinned to Haemophilus Influenzae as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Post-marketing safety surveillance of Haemophilus influenzae Type b conjugate vaccine in children aged 3 months to 5 years in Jiangsu, China.
  Human vaccines & immunotherapeutics · 2026 · Zhou Y, Tang R, Wei M, et al.
  PMID 42216576DOI 10.1080/21645515.2026.2677876
• Product- and schedule-specific vaccine effectiveness against invasive Haemophilus influenzae serotype b (Hib) disease, The Netherlands, 2005 to 2023.
  Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026 · Bertran M, de Gier B, Garcia Vilaplana T, et al.
  PMID 42141871DOI 10.2807/1560-7917.ES.2026.31.19.2500699
• Highly transformable Haemophilus influenzae as a potential amplifier of quinolone resistance dissemination.
  The Journal of antimicrobial chemotherapy · 2026 · Wajima T, Kubota T, Tanaka E, et al.
  PMID 42108537DOI 10.1093/jac/dkag160
• Establishment of tentative epidemiological cutoff values of faropenem against Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Haemophilus influenzae, and Streptococcus pneumoniae.
  Frontiers in cellular and infection microbiology · 2026 · Wu S, Yang Y, Yin D, et al.
  PMID 42100660DOI 10.3389/fcimb.2026.1757254
• Epidemiological & demographic trends of Haemophilus influenzae in Malaysia's southern region: data insights from tertiary level hospital and nearby facilities.
  The Malaysian journal of pathology · 2026 · Liow YL, Aziera S, Aidil F, et al.
  PMID 42059170
• Haemophilus influenzae: imposter, mucosal pathobiont, and model organism.
  Journal of bacteriology · 2026 · Amero K, St Geme JW 3rd
  PMID 42017798DOI 10.1128/jb.00083-26
• Severity and recurrence of Haemophilus influenzae pneumonia in adults are frequent and associated with distinct pathogenic patterns.
  International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2026 · Hamon A, Garzaro M, Eiferman V, et al.
  PMID 41967569DOI 10.1016/j.ijid.2026.108698
• Surveillance of epidemiological characteristics and temporal trends in antimicrobial resistance of Haemophilus influenzae in pediatric lower respiratory tract infections (2021-2024).
  Scientific reports · 2026 · Li W, Bai Y, Yang C, et al.
  PMID 41965912DOI 10.1038/s41598-026-48271-2

The 10 most recently updated of 317 ClinicalTrials.gov registrations naming Haemophilus Influenzae as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
  Recruiting · Phase 3 · Interventional · 6,000 enrolled · Pfizer
  NCT07160244updated 2026-06-09
• Oral Bacterial Extract for the Prevention of Wheezing Lower Respiratory Tract Illness
  Completed · Phase 2 · Interventional · 822 enrolled · University of Arizona
  NCT02148796updated 2026-06-02
• A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants
  Active not recruiting · Phase 2 · Interventional · 215 enrolled · GlaxoSmithKline
  NCT06213506updated 2026-05-19
• Infant Malaria Vaccine Schedule Optimization
  Recruiting · Phase 2 · Interventional · 964 enrolled · PATH
  NCT06879327updated 2026-05-15
• Safety of Simultaneous mRNA COVID-19 Vaccine With Other Childhood Vaccines in Young Children
  Completed · Phase 4 · Interventional · 347 enrolled · Duke University
  NCT06038617updated 2026-05-13
• Amoxicillin/Clavulanic Acid Susceptibility in Acute Community-acquired Pneumonia Requiring Intensive Care Management
  Completed · Observational · 104 enrolled · Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
  NCT07322549updated 2026-04-14
• Integrating Point of Care Testing (POCT) For Newborn Screening and Early Care for Sickle Cell Disease in Yopougon, Côte d'Ivoire
  Not yet recruiting · Phase 4 · Interventional · 120 enrolled · Swiss Tropical & Public Health Institute
  NCT07488520updated 2026-03-23
• Exploratory Clinical Study of MT-2301
  Completed · Phase 2 · Interventional · 154 enrolled · Tanabe Pharma Corporation
  NCT02140047updated 2026-03-17
• Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers
  Terminated · Phase 3 · Interventional · 2,226 enrolled · Sanofi Pasteur, a Sanofi Company
  NCT06397768updated 2026-02-03
• A Study on the Immune Response and Safety of a Multicomponent Shigella Vaccine in Preventing Shigellosis in Infants
  Completed · Phase 2 · Interventional · 200 enrolled · GlaxoSmithKline
  NCT06663436updated 2026-01-30

Frequently asked questions

What is Haemophilus Influenzae used for?

According to FDA labeling, Haemophilus Influenzae carries indications including: HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to upper respiratory infections including fever, cough and runny nose.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.